Windtree Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell WINT and other ETFs, options, and stocks.About WINT
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases.
CEOJed Andrew Latkin
CEOJed Andrew Latkin
Employees14
Employees14
HeadquartersWarrington, Pennsylvania
HeadquartersWarrington, Pennsylvania
Founded1992
Founded1992
Employees14
Employees14
WINT Key Statistics
Market cap3.66M
Market cap3.66M
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume165.30K
Average volume165.30K
High today$1.31
High today$1.31
Low today$0.9606
Low today$0.9606
Open price$1.19
Open price$1.19
Volume695.75K
Volume695.75K
52 Week high$737.44
52 Week high$737.44
52 Week low$0.9606
52 Week low$0.9606
WINT News
TipRanks 15h
Windtree Therapeutics Raises $2.5M in Private PlacementThe latest update is out from Windtree Therapeutics ( (WINT) ). On April 19, 2025, Windtree Therapeutics, through its subsidiary WINT Real Estate, LLC, entered...
People also own
Based on the portfolios of people who own WINT. This list is generated using Robinhood data, and it’s not a recommendation.